Clinical Trial Update: Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT) [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial evaluating prevention of micro-architectural bone decay in men with non-metastatic prostate cancer on androgen deprivation therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Austin Health | Conditions: Prostate Cancer | Phase 2, Phase 3 | Status: COMPLETED